September 30, 2021 | CRISPR, Impetus Digital, Jessica Schwaber, Natalie Yeadon, Solupore, allogeneic therapies, cell engineering, cell therapy, gene therapy, gene-editing, non-viral modalities, precision medicine, viral modalities
Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing the full potential of cell & gene therapy, and much more.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public…
Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson’s community catalyzed the founding of Charco and how innovative medical devices and software can improve…
Although many people are starting to go back to their offices, at least for part of the week, many others are looking at permanent ‘Work From Home’ (WFH) set-ups. At…
I’m excited to share another Impetus top-10 list! This time, I focus on the top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory…
Dvorah Richler, Head of Soaring with Roche, and Michael Duong, Head of Innovation at Michael Duong, discuss the 5 healthcare challenges that Soaring with Roche aims to solve through innovative…
In this article, we dive into the world of hybrid meetings, including the different definitions of “hybrid,” the importance of over-time engagement, and more.
We recently shared our top-10 creative ways to engage your advisors and most important advisor questions. In Impetus Digital’s third top-10 list, we focus on how to optimize asynchronous virtual…
Alex Gilbert, Head of Digital Medicines Development & Life Sciences Partnerships at Huma, explores virtual & decentralized trials, digital biomarkers, digital-first delivery of care, at-home hospitals, and many other thought-provoking…
While Pharma was already slowly pivoting towards virtual events as a substitute for, or supplement to, in-person meetings, COVID-19 quickly changed virtual events from a nice-to-have to a must. With…
Dr. Patrick Carroll, Chief Medical Officer at Vida Health, discusses the importance of using a “whole health” approach to chronic disease management, how and why the human connection with a…
